1.
Real-world efficacy, safety, and usability of a microvolume eyedrop delivery device in glaucoma: prospective randomized crossover trial.
Steger Jennifer S, Capó-Aponte José E, Papp Alexandra, Schulte Alexandra J, Grewal Eric P, Song Allisa J et al.
J Cataract Refract SurgApr 20260 citationsRandomized Controlled Trial
Microdrops via Nanodropper showed better IOP lowering, reduced bottle exhaustion, and fewer side effects than conventional drops, potentially improving glaucoma treatment adherence and control.